VBLT Vascular Biogenics Ltd.

Vascular Biogenics Ltd is a clinical-stage bio-pharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

As of 10/03/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  10/01/2014
Outstanding shares:  69,326,950
Average volume:  2,276,590
Market cap:   $10,856,600
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -0.37
PB ratio:   0.29
PS ratio:   14.14
Return on equity:   -57.34%
Net income %:   -3,895.83%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy